RDY — Dr Reddys Laboratories Balance Sheet
0.000.00%
- $11.88bn
- $11.76bn
- IN₹326.44bn
- 84
- 38
- 42
- 56
Annual balance sheet for Dr Reddys Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
| 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IAS | IAS | IAS | IAS | IAS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 34,387 | 44,207 | 61,642 | 81,313 | 57,759 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 61,337 | 78,083 | 87,993 | 98,831 | 110,703 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 145,503 | 177,823 | 204,255 | 248,053 | 250,181 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 56,861 | 61,665 | 66,294 | 75,997 | 96,978 | 
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 266,168 | 297,469 | 322,851 | 388,638 | 494,266 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 81,038 | 97,658 | 85,721 | 95,880 | 130,338 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 89,751 | 105,345 | 89,990 | 106,090 | 158,770 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 176,417 | 192,124 | 232,861 | 282,548 | 335,496 | 
| Total Liabilities & Shareholders' Equity | 266,168 | 297,469 | 322,851 | 388,638 | 494,266 | 
| Total Common Shares Outstanding |